CONCLUSION
The study concludes that neonatal hyperbilirubinemia is a recognizable cause of auditory neuropathy and neurodevelopmental sequelae. Peak Serum Bilirubin is linearly associated with BERA changes and neurodevelopmental sequelae. Patients having ABO incompatibility and receiving exchange transfusion have higher odds of neurodevelopmental and BERA abnormalities. Regular follow-up and early intervention may help infants with neonatal hyperblirubinemia to have better neurodevelopmental and auditory outcomes.
References